Journals / Turkish Thoracic Journal / 2020 / Cilt: 21 - Sayı: 2

2019 ARIA Care Pathways for Allergic Rhinitis-Turkey

ARIA 2019, Allerjik Rinite Tedavi Yaklaşımı-Türkiye

Pages
122–133
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

An executive summary is presented in this article, which will be customized in different countries or regions in order to adjust the conclusions of the papers for local use and health systems.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The evaluation of real-life integrated care pathways (ICPs) was recommended for digitally enabled, integrated, person-centered care for rhinitis and asthma multimorbidity embedding environmental exposure.
📊
Key Findings & Data:A meeting was held in Paris on December 3, 2018, during which two separate documents were produced.
💡
Conclusion & Impact:An executive summary is presented in this article, which will be customized in different countries or regions in order to adjust the conclusions of the papers for local use and health systems.
🔬Design:Research Article
📍Scope:2018 Verileri
⚙️Variables:Domain Parameters

Abstract

The evaluation of real-life integrated care pathways (ICPs) was recommended for digitally enabled, integrated, person-centered care for rhinitis and asthma multimorbidity embedding environmental exposure. ICPs are structured multidisciplinary care plans detailing key steps of patient care. They promote the translation of guideline recommendations into local protocols and their application to clinical practice. In allergic rhinitis, there is an urgent need to develop next-generation guidelines for pharmacotherapy and ICPs for allergen immunotherapy. A meeting was held in Paris on December 3, 2018, during which two separate documents were produced. An executive summary is presented in this article, which will be customized in different countries or regions in order to adjust the conclusions of the papers for local use and health systems.

Özet

Gerçek yaşamda, çevresel maruziyetlerin de etkilediği rinit ve astım mültimorbidite durumlarında, dijitalleşmiş ve kişiye odaklanan tedaviler içinbütünleştirilmiş tedavi yollarının değerlendirilmesi önerilmektedir. Gerçek yaşamdaki bu durum mültisipliner bir yaklaşımla basamaklandırılıp,rehberilerinde ülkelerdeki gereksinimlere göre değiştilmesini gerektirebilir. Allerjik rinitte hem farmakoterapi hem immünoterapi açısından acilyeni yaklaşımlara ihtiyaç olduğu görülmüştür. 3. Aralık 2018’de Paris’te bir toplantı yapılmış ve iki ayrı belge hazırlanmıştır. Bu yayında bunlaraait bir özet sunulup, ülkeye ve sağlık sistemine uygun kullanımın çerçevesi oluşturulmak istenmiştir.

🔖

Cite This Article

YORGANCIOĞLU, A. A., GEMİCİOĞLU, B., CİNGİ, C., KALAYCI, Ö., KALYONCU, A. F., BACHERT, C., HELLİNGS, P., PFAAR, O., SCHÜNEMANN, H. J., WALLACE, D., BEDBROOK, A., CZARLEWSKI, W., BOUSQUET, J. (2020). 2019 ARIA Care Pathways for Allergic Rhinitis-Turkey. Turkish Thoracic Journal, Cilt: 21 - Sayı: 2, 122–133. https://ajindex.com/articles/417966

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Bousquet J, Arnavielhe S, Bedbrook A, et al. MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence. Clin Transl Allergy 2018
  2. [CrossRef] 2. Bousquet J, Anto JM, Annesi-Maesano I, et al. POLLAR: Impact of air POLLution on Asthma and Rhinitis
  3. a European Institute of Innovation and Technology Health (EIT Health) project. Clin Transl Allergy 2018
  4. [CrossRef] 3. Bousquet J, Schunemann HJ, Togias A, et al. Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases. Clin Transl Allergy 2019
  5. [CrossRef] 4. Palmer K, Marengoni A, Forjaz MJ, et al. Multimorbidity care model: Recommendations from the consensus meeting of the Joint Action on Chronic Diseases and Promoting Healthy Ageing across the Life Cycle (JA-CHRODIS). Health Policy 2018
  6. [CrossRef] 5. Bousquet J, Addis A, Adcock I, et al. Integrated care pathways for airway diseases (AIRWAYS-ICPs). Eur Respir J 2014
  7. [CrossRef] 6. Bousquet J, Bedbrook A, Czarlewski W, et al. Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma. Clin Transl Allergy 2019
  8. [CrossRef] 7. Hellings PW, Borrelli D, Pietikainen S, et al. European Summit on the Prevention and Self-Management of Chronic Respiratory Diseases: report of the European Union Parliament Summit (29 March 2017). Clin Transl Allergy 2017
  9. [CrossRef] 8. Bédard A, Basagaña X, Anto JM, et al. Mobile technology offers novel insights into the control and treatment of allergic rhinitis: The MASK study. J Allergy Clin Immunol 2019
  10. [CrossRef] 9. Civelek E, Yavuz ST, Boz AB, et al. Epidemiology and burden of rhinitis and rhinoconjunctivitis in 9- to 11-year-old children. Am J Rhinol Allergy 2010
  11. [CrossRef] 10. Türk Toraks Derneği Astım Tanı ve Tedavi Rehberi. 2016 Güncellemesi. Turkish Thoracic J 2016
  12. 17(Suppl): 1-74. 11. Gurkan F, Davutoglu M, Bilici M, et al. Asthmatic children and risk factors at a province in the southeast of Turkey. Allergol Immunopathol (Madr) 2002
  13. v [CrossRef] 12. Kocabas CN, Civelek E, Sackesen C, et al. Burden of rhinitis in children with asthma. Pediatr Pulmonol 2005
  14. [CrossRef] 13. Gemicioglu B, Bayram H, Cimrin A, et al. Asthma control and adherence in newly diagnosed young and elderly adult patients with asthma in Turkey. J Asthma 2019
  15. [CrossRef] 14. Civelek E, Soyer OU,